ArticleThe Journal of biological chemistry2026
S-acylation and membrane localization of the small GTPase ARL15 are mediated by the Golgi S-acyltransferases ZDHHC7 and ZDHHC3.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ARL15 is a member of the ARF-like (ARL) family of small GTPases, implicated in the regulation of ion homeostasis and metabolic signaling pathways. Although ARL15 has been suggested to undergo S-acylation-a reversible lipid modification that governs membrane association and trafficking-the stoichiometry of this modification and the responsible S-acyltransferases have remained unclear. Here, we systematically characterized the S-acylation of ARL15 and identified the enzymes mediating this modification. Using acyl-PEGyl exchange gel-shift assays, we show that ARL15 is triply S-acylated at three conserved N-terminal cysteine residues (Cys17, Cys22, and Cys23) in HEK293T cells. Single cysteine-to-serine mutations substantially reduced S-acylation, whereas substitution of all three cysteines abolished it entirely. Loss of S-acylation disrupted membrane association of ARL15, as shown by confocal imaging and subcellular fractionation. A candidate screen using siRNA knockdown and CRISPR/Cas9-mediated gene disruption revealed that the Golgi-localized S-acyltransferases ZDHHC7 and ZDHHC3 mediate ARL15 S-acylation in a partially redundant or parallel manner. Dual inhibition of both enzymes led to a marked reduction in S-acylation and redistributed ARL15 from membranes to the cytosol. These findings elucidate the stoichiometry and enzymatic regulation of ARL15 S-acylation and provide mechanistic insight into its subcellular localization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.